Professor | Wengang Li | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Wengang Li
Contact Information	Lwg11861@163.com
Language ability	Chinese, English
Province	Fujian

Upload Avatar (500 x 500)

Name

Wengang Li

Contact Information

Lwg11861@163.com

Language ability

Chinese, English

Province

Fujian

University/Lab Affiliation and Title	Xiamen University
Faculty	Medical
Academic Background & Achievements	1988-1993 Bachelor of Medicine: Bethune Medical University 1998-2000 Master of Medicine: Bethune Medical University, Sino-Japanese Friendship Hospital 2001-2002 Advanced Studies: Second Military Medical University, Eastern Hepatobiliary Surgery Hospital 2002-2005 Doctor of Medicine: Chinese PLA General Hospital, Hepatobiliary Surgery 2012-2013 Visiting Scholar: University of Miami, Jackson Memorial Hospital
Work Experience	2005.8-2007.1 - Xiamen University First Affiliated Hospital - Attending Physician 2007.2-2008.7 - Shanghai Jiao Tong University First People's Hospital Liver Transplant Center - Postdoctoral 2008.8-2011.2 - Xiamen University First Affiliated Hospital - Associate Chief Physician 2011.3-2018.5 - Xiamen University Chenggong Hospital - Chief Physician 2018.6-present - Xiamen University Xiang'an Hospital - Chief Physician 2018.6-present - Xiamen University School of Medicine - Vice Dean 2018.6-present - Xiamen University Cancer Research Center - Deputy Director
Awards	2017: Xiamen Science and Technology Major Contribution Award 2014: Fujian Science and Technology Innovation Leading Talent (First Batch) 2013: Xiamen Science and Technology Innovation Outstanding Talent Award 2013: Fujian Science and Technology Progress Second Prize 2013: Xiamen Science and Technology Progress Second Prize 2008: Chinese PLA Science and Technology Progress Second Prize 2007: Ministry of Education Higher Education Science and Technology Progress First Prize 2007: Fourth Fujian Youth May Fourth Medal 2006: Xiamen Science and Technology Progress First Prize

University/Lab Affiliation and Title

Xiamen University

Faculty

Medical

Academic Background & Achievements

1988-1993 Bachelor of Medicine: Bethune Medical University
1998-2000 Master of Medicine: Bethune Medical University, Sino-Japanese Friendship Hospital
2001-2002 Advanced Studies: Second Military Medical University, Eastern Hepatobiliary Surgery Hospital
2002-2005 Doctor of Medicine: Chinese PLA General Hospital, Hepatobiliary Surgery
2012-2013 Visiting Scholar: University of Miami, Jackson Memorial Hospital

Work Experience

2005.8-2007.1 - Xiamen University First Affiliated Hospital - Attending Physician
2007.2-2008.7 - Shanghai Jiao Tong University First People's Hospital Liver Transplant Center - Postdoctoral
2008.8-2011.2 - Xiamen University First Affiliated Hospital - Associate Chief Physician
2011.3-2018.5 - Xiamen University Chenggong Hospital - Chief Physician
2018.6-present - Xiamen University Xiang'an Hospital - Chief Physician
2018.6-present - Xiamen University School of Medicine - Vice Dean
2018.6-present - Xiamen University Cancer Research Center - Deputy Director

Awards

2017: Xiamen Science and Technology Major Contribution Award
2014: Fujian Science and Technology Innovation Leading Talent (First Batch)
2013: Xiamen Science and Technology Innovation Outstanding Talent Award
2013: Fujian Science and Technology Progress Second Prize
2013: Xiamen Science and Technology Progress Second Prize
2008: Chinese PLA Science and Technology Progress Second Prize
2007: Ministry of Education Higher Education Science and Technology Progress First Prize
2007: Fourth Fujian Youth May Fourth Medal
2006: Xiamen Science and Technology Progress First Prize

Areas of Focus	Mechanism and precision diagnosis and treatment of abdominal tumors, especially retroperitoneal tumors
Publications	Histone Demethylase JMJD2D Interacts with Beta-catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice., Peng Kesong, Kou Lele, Yu Li, Bai Chaonan, Li Ming, Mo Pingli, Li Wengang, Yu Chundong, 2019 Amplified in Breast Cancer 1 Enhances Human Cholangiocarcinoma Growth and Chemoresistance by Simultaneous Activation of Akt and Nrf2 Pathways., Qiang Chen, Wenjiao Li, Yunyan Wan, Xiaochun Xia, Qiao Wu, Yanling Chen, Zhide Lai, Chundong Yu, Wengang Li, 2012 Hepatitis B Virus X Protein Stabilizes Amplified in Breast Cancer 1 Protein and Cooperates With It to Promote Human Hepatocellular Carcinoma Cell Invasiveness., Yonghong Liu, Zhangwei Tong, Ting Li, Qiang Chen, Luting Zhuo, Wengang Li, Ray-Chang Wu, Chundong Yu, 2012 Overexpression of transcriptional coactivator AIB1 promotes hepatocellular carcinoma progression by enhancing cell proliferation and invasiveness., Yixiang Xu, Qiang Chen, Wen-Gang Li, Xinhui Su, Tenghui Chen, Yang Zhao, Chundong Yu, 2010 Bio-engineered nano-vesicles for IR820 delivery: a therapy platform for cancer by surgery and photothermal therapy., Zhang Xiaojie, Zhou Changsheng, Wu Fanghua, Gao Chang, Liu Qianqian, Lv Peng, Li Ming, Huang Liyong, Wu Ting, Li Wengang, 2022 Demethylase JMJD2D induces PD-L1 expression to promote colorectal cancer immune escape by enhancing IFNGR1-STAT3-IRF1 signaling., Chen Qiang, Zhuang Shuqing, Hong Yilin, Yang Lingtao, Guo Peng, Mo Pingli, Peng Kesong, Li Wengang, Xiao Nengming, Yu Chundong, 2022 RNA‐binding protein RBM24 represses colorectal tumourigenesis by stabilising PTEN mRNA., Xia RM, Liu T, Li WG, Xu XQ, 2021 Establishment of an orthotopic perirenal space xenograft mouse model of retroperitoneal sarcoma., Xie Fu'an, Qin Dongmei, Lian Lanlan, Li Ming, Kong Xu, Xia Xiaogang, Yu Chundong, Luo Chenghua, Li Wengang, 2021 Demethylase-independent function of JMJD2D as a novel antagonist of p53 to promote Liver Cancer initiation and progression., Li Ming, Deng Yuan, Zhuo Minghui, Zhou Hui, Kong Xu, Xia Xiaogang, Su Zhaojie, Chen Qiang, Guo Peng, Mo Pingli, Yu Chundong, Li Wengang, 2020 Inflammation-induced JMJD2D promotes colitis recovery and colon tumorigenesis by activating Hedgehog signaling., Zhuo Minghui, Chen Wenbo, Shang Shaohui, Guo Peng, Peng Kesong, Li Ming, Mo Pingli, Zhang Yongyou, Qiu Xingfeng, Li Wengang, Yu Chundong, 2020 Oncogenic Potential of Retinoic Acid Receptor-γ in Hepatocellular Carcinoma., Ting-Dong Yan, Hua Wu, Hai-Ping Zhang, Na Lu, Ping Ye, Feng-Hai Yu, Hu Zhou, Wen-Gang Li, et al., 2010

Areas of Focus

Mechanism and precision diagnosis and treatment of abdominal tumors, especially retroperitoneal tumors

Publications

Histone Demethylase JMJD2D Interacts with Beta-catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice., Peng Kesong, Kou Lele, Yu Li, Bai Chaonan, Li Ming, Mo Pingli, Li Wengang, Yu Chundong, 2019
Amplified in Breast Cancer 1 Enhances Human Cholangiocarcinoma Growth and Chemoresistance by Simultaneous Activation of Akt and Nrf2 Pathways., Qiang Chen, Wenjiao Li, Yunyan Wan, Xiaochun Xia, Qiao Wu, Yanling Chen, Zhide Lai, Chundong Yu, Wengang Li, 2012
Hepatitis B Virus X Protein Stabilizes Amplified in Breast Cancer 1 Protein and Cooperates With It to Promote Human Hepatocellular Carcinoma Cell Invasiveness., Yonghong Liu, Zhangwei Tong, Ting Li, Qiang Chen, Luting Zhuo, Wengang Li, Ray-Chang Wu, Chundong Yu, 2012
Overexpression of transcriptional coactivator AIB1 promotes hepatocellular carcinoma progression by enhancing cell proliferation and invasiveness., Yixiang Xu, Qiang Chen, Wen-Gang Li, Xinhui Su, Tenghui Chen, Yang Zhao, Chundong Yu, 2010
Bio-engineered nano-vesicles for IR820 delivery: a therapy platform for cancer by surgery and photothermal therapy., Zhang Xiaojie, Zhou Changsheng, Wu Fanghua, Gao Chang, Liu Qianqian, Lv Peng, Li Ming, Huang Liyong, Wu Ting, Li Wengang, 2022
Demethylase JMJD2D induces PD-L1 expression to promote colorectal cancer immune escape by enhancing IFNGR1-STAT3-IRF1 signaling., Chen Qiang, Zhuang Shuqing, Hong Yilin, Yang Lingtao, Guo Peng, Mo Pingli, Peng Kesong, Li Wengang, Xiao Nengming, Yu Chundong, 2022
RNA‐binding protein RBM24 represses colorectal tumourigenesis by stabilising PTEN mRNA., Xia RM, Liu T, Li WG, Xu XQ, 2021
Establishment of an orthotopic perirenal space xenograft mouse model of retroperitoneal sarcoma., Xie Fu'an, Qin Dongmei, Lian Lanlan, Li Ming, Kong Xu, Xia Xiaogang, Yu Chundong, Luo Chenghua, Li Wengang, 2021
Demethylase-independent function of JMJD2D as a novel antagonist of p53 to promote Liver Cancer initiation and progression., Li Ming, Deng Yuan, Zhuo Minghui, Zhou Hui, Kong Xu, Xia Xiaogang, Su Zhaojie, Chen Qiang, Guo Peng, Mo Pingli, Yu Chundong, Li Wengang, 2020
Inflammation-induced JMJD2D promotes colitis recovery and colon tumorigenesis by activating Hedgehog signaling., Zhuo Minghui, Chen Wenbo, Shang Shaohui, Guo Peng, Peng Kesong, Li Ming, Mo Pingli, Zhang Yongyou, Qiu Xingfeng, Li Wengang, Yu Chundong, 2020
Oncogenic Potential of Retinoic Acid Receptor-γ in Hepatocellular Carcinoma., Ting-Dong Yan, Hua Wu, Hai-Ping Zhang, Na Lu, Ping Ye, Feng-Hai Yu, Hu Zhou, Wen-Gang Li, et al., 2010

Abdominal Tumors Precision Diagnosis Treatment Retroperitoneal Tumors Mechanism Research Oncology Surgery Clinical Medicine

Xiao Xu - Zhejiang University

Jimin Shao - Zhejiang University

Maode Lai - Zhejiang University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us